Featured
Interactive tools
Interactive data visualizations of antibiotic use and resistance in North America and Europe
On 17 September, the meeting will be devoted to The Affordable Medicines Facility-malaria and future scenarios, and on 18 September – to the developing febrile illness management paradigm. The principal investigators of the AMFm independent evaluation, the analysts working on the transition path from AMFm Phase 1, members of the Global Fund and Roll Back Malaria advisory committee, and many experts in febrile illnesses—including malaria and pneumonia—will present their work and views at this meeting, before Global Fund board decisions are taken in November.
Thanks to all who participated in the meeting and to those who followed our feed. Please follow @CDDEP on Twitter for continued updates.